Search

everythinglearnresearchcommunity

for

Search:↓

Women with severe acne, hirsutism, and androgenic alopecia often have higher levels of certain androgens, but the specific pattern can't be predicted just by looking at symptoms.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Low IGF-1 and high HDL cholesterol levels are linked to more hair loss in middle-aged women.

Lower zinc levels may predict less effective hair loss treatment.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

People with hair loss have worse cholesterol levels, possibly linking hair loss to heart problems.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

Manage women's cholesterol with diet, exercise, and careful treatment choices, especially during pregnancy, PCOS, and menopause.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Stress and alcohol affect brain chemicals differently in rats, mice, and humans, influenced by genetic differences.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Normal levels for certain hormones in Chinese women of reproductive age were identified.

PSA can help diagnose high androgen levels in women.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Hair analysis for drugs needs a better understanding of how drugs enter hair, considering factors like hair structure and pigmentation.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.